BioSpace News Archive

Biotech Bay

Bay Area Biotech Companies Hiring Now

The Biotech Bay region is home to 3,418 life sciences companies and 96,574 employees making an average of $148,285. Here’s a look at a few of the bay area biotech companies hiring now.

July 15, 2021
·
6 min read
·
Heather McKenzie
Genetown

Startup Launches to “Hijack” Body’s Natural Cell Clearing Process

PAQ Therapeutics secured $30 million in Series A financing to develop new therapeutics for diseases by enhancing the body’s ability to clear out damaged cells so it can regenerate newer, healthier ones.

July 15, 2021
·
3 min read
·
Alex Keown
Drug Development

Genetically Modifying Bats Could Prevent the Next Pandemic, Scientists Say

The next COVID pandemic could be prevented by using a gene drive to preemptively edit the genome of bats to prevent them from becoming hosts for coronaviruses, according to a proposal by scientists from Israel’s Interdisciplinary Center Herzelia and the National Institutes of Health.

July 15, 2021
·
6 min read
·
Gail Dutton
With $172 Million Raise, Wugen Brings Natural Killer Therapies to Solid Tumors Next

Its lead product, WU-NK-101, is already proving itself in an ongoing Phase I/II trial, demonstrating an “impressive complete response rate in relapsed/refractory AML.”

July 15, 2021
·
2 min read
·
Kate Goodwin
Deals

Diagnostics Testing Company Joins SPAC Craze with Planned Nasdaq Listing

Prenetics, which is a diagnostics and genetics testing company, will merge with Artisan Acquisition, a SPAC company backed by Adrian Cheng, chief executive officer of Hong Kong’s New World Development.

July 15, 2021
·
2 min read
·
Alex Keown
Drug Development

Research Roundup: A Protein that Stops Cancer Metastasis and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

July 15, 2021
·
5 min read
·
Mark Terry
Business

BioSpace Movers & Shakers, July 16

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

July 15, 2021
·
9 min read
·
Alex Keown
Genetown

Biogen’s Aduhelm Faces More Obstacles as Some Insurers Balking at Paying for Drug

Biogen’s controversial Alzheimer’s drug Aduhelm (aducanumab) is facing yet another obstacle as at least six affiliates of Blue Cross Blue Shield likely won’t cover the drug.

July 15, 2021
·
5 min read
·
Mark Terry
FDA

FDA Shows a Firm Hand, Publicly Scolding Biopharmas Over Issues of Concern

The FDA has historically tended to keep more contentious relationships with some companies private. But recently, the agency appears to be publicly scolding some biopharma companies.

July 15, 2021
·
4 min read
·
Mark Terry
Drug Development

Neuroprosthesis Device Allows “Speech” for Those Who Have Lost Their Voice

The device is at the core of the BRAVO trial, which evaluates signals to control complex devices for motor and speech in adults who have been severely affected by neurological disorders.

July 15, 2021
·
3 min read
·
Vanessa Doctor, RN